US4299768AExpiredUtilityPatentIndex 72
1-Pyrrole- and 1-pyrrolidine-carboxylic acid derivatives and process for preparing the same
Est. expiryJun 12, 1998(expired)· nominal 20-yr term from priority
C07D 207/08C07D 207/273
72
PatentIndex Score
8
Cited by
3
References
9
Claims
Abstract
1-Pyrrole- and 1-pyrrolidine-carboxylic acid derivatives corresponding to the general formula: ##STR1## in which R represents an alkyl radical having from 1 to 4 carbon atoms, preferably ethyl, and Am represents a group: ##STR2## wherein R 1 represents a 3-oxo-alkyl radical ##STR3## or a 3-oxo-alkenyl radical ##STR4## and R 2 represents hydrogen or R 1 and R 2 , when they are identical, each represent hydrogen, ##STR5## R 3 representing an alkyl radical having from 1 to 5 carbon atoms with the proviso that when R 1 and R 2 are simultaneously hydrogen, Am represents the group A. The novel derivatives are useful as intermediates for synthetizing azaprostaglandines.
Claims
exact text as granted — not AI-modifiedWe claim:
1. 2,5-Dihydro-1-pyrrole-carboxylic acid derivatives corresponding to the formula: ##STR18## wherein R represents an alkyl radical having from 1 to 4 carbon atoms, R 1 represents a 3-oxo-alkyl radical ##STR19## or a 3-oxo-alkenyl radical ##STR20## R 2 represents hydrogen or R 1 and R 2 , when they are identical, each represents ##STR21## R 3 representing an alkyl radical having from 1 to 5 carbon atoms.
2. Ethyl 3-(1'-pyrrolidinyl)-2,5-dihydro-1-pyrrole-carboxylate.
3. Ethyl 4-(3'-oxo-butyl)-3-(1'-pyrrolidinyl)-2,5-dihydro-1-pyrrole-carboxylate.
4. Ethyl 4-(3'-oxo-butyl)-3-oxo-1-pyrrolidine-carboxylate.
5. Ethyl 4-(3'-oxo-octyl)-3-(1'-pyrrolidinyl)-2,5-dihydro-1-pyrrole-carboxylate.
6. Ethyl 4-(3'-oxo-octyl)-3-oxo-1-pyrrolidine-carboxylate.
7. Ethyl 4-(3'-oxo-1'-octenyl)-3-(1'-pyrrolidinyl)-2,5-dihydro-1-pyrrole-carboxylate.
8. Ethyl 2,4-di-(3'-oxo-butyl)-3-(1'-pyrrolidinyl)-2,5-dihydro-1-pyrrole-carboxylate.
9. Ethyl 2,4-di-(3'-oxo-butyl)-3-oxo-1-pyrrolidine-carboxylate.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.